Marketing-authorisation holder
Lupin Pharma Canada Limited
34 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
34 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 34
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARMLUPEG6 mg / 0.6 ml · Solution | Pegfilgrastim | Canada | Authorised | |
| FEMYSO200 mg + 200 mcg · Kit, Tablet | Mifepristone, Misoprostol | Canada | Marketed | 2026 |
| JENCYCLA0.35 mg · Tablet | Norethindrone | Canada | Marketed | 2015 |
| LAYLAA 2120 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 2023 |
| LAYLAA 2820 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 2023 |
| LUPIN-CELECOXIB200 mg · Capsule | Celecoxib | Canada | Authorised | |
| LUPIN-CELECOXIB100 mg · Capsule | Celecoxib | Canada | Authorised | |
| LUPIN-CEPHALEXIN250 mg / 5 ml · Powder For Suspension | Cefalexin | Canada | Marketed | 2018 |
| LUPIN-CEPHALEXIN125 mg / 5 ml · Powder For Suspension | Cefalexin | Canada | Marketed | 2018 |
| LUPIN-CEPHALEXIN250 mg · Tablet | Cefalexin | Canada | Marketed | 2025 |
| LUPIN-CEPHALEXIN500 mg · Tablet | Cefalexin | Canada | Marketed | 2025 |
| LUPIN-ESTRADIOL0.5 mg · Tablet | Estradiol | Canada | Marketed | 2016 |
| LUPIN-ESTRADIOL1 mg · Tablet | Estradiol | Canada | Marketed | 2016 |
| LUPIN-ESTRADIOL2 mg · Tablet | Estradiol | Canada | Marketed | 2016 |
| LUPIN-GLUCAGON1 mg / vial · Powder For Solution | Glucagon | Canada | Authorised | |
| LUPIN-LETERMOVIR480 mg · Tablet | Letermovir | Canada | Marketed | 2026 |
| LUPIN-LETERMOVIR240 mg · Tablet | Letermovir | Canada | Marketed | 2026 |
| LUPIN-PROPRANOLOL LA160 mg · Capsule (Extended-Release) | Propranolol | Canada | Marketed | 2023 |
| LUPIN-PROPRANOLOL LA120 mg · Capsule (Extended-Release) | Propranolol | Canada | Marketed | 2023 |
| LUPIN-PROPRANOLOL LA60 mg · Capsule (Extended-Release) | Propranolol | Canada | Marketed | 2023 |
| LUPIN-PROPRANOLOL LA80 mg · Capsule (Extended-Release) | Propranolol | Canada | Marketed | 2023 |
| LUPIN-RIFAXIMIN550 mg · Tablet | Rifaximin | Canada | Authorised | |
| LUPIN-SODIUM CROMOGLICATE100 mg · Capsule | Cromolyn | Canada | Authorised | |
| LUPIN-TIOTROPIUM18 mcg · Capsule | Tiotropium bromide | Canada | Marketed | 2023 |
| LUPIN-TOLVAPTAN30 mg + 60 mg · Tablet | Tolvaptan | Canada | Marketed | 2026 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 34 | 33 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.